Neovastat (Æ-941) in addition to combined modality therapy for locally-advanced unresectable non-small cell lung cancer (NSCLC):: An NCI-sponsored multicenter phase III study.
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- November 2001
has subject area
- 1112 Oncology and Carcinogenesis (FoR)
- Oncology & Carcinogenesis (Science Metrix)
published in
- Clinical Cancer Research Journal